Clovis Oncology Earning Date (CLVS)

USA |NASDAQ |USD

CLVS Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 2, 2022 Jun 2022 $-0.41 - $-0.61
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 2, 2022 Jun 2022 $39.89M - $36.82M

Clovis Oncology's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 2022.

CLVS Earnings Date & History Chart

CLVS Earnings & Revenue Forecast

CLVS Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Jun 2022 4 $-0.41 $-0.56 $-0.29
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $-1.65 $-2.08 $-1.16
Dec 2023 4 $-0.95 $-1.10 $-0.72

CLVS Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Jun 2022 2 / 0 $-0.42 $-0.42 $-0.33
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 2 / 0 $-1.67 $-1.67 $-1.48
Dec 2023 3 / 0 $-0.99 $-0.99 $-0.91

CLVS Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Jun 2022 4 $39.89M $38.52M $41.54M
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $166.38M $161.00M $172.29M
Dec 2023 4 $238.01M $203.96M $291.64M

CLVS Earnings Date & Revenue History

CLVS Earnings History

|
Show More
Show More

CLVS Revenue History

|
Show More
Show More

Clovis Oncology Next Earnings Date & Report

CLVS Next Earnings Date & Report Preview: Jun 2022 (FQ)

CLVS's next earnings date is Tuesday, Aug 2, 2022 for the fiscal quarter ending Jun 30, 2022.

According to analysts, the average EPS estimation for Clovis Oncology's next quarterly earnings is $-0.41, with a low EPS estimation of $-0.56, and a high estimation of $-0.29.

Over the last 1 month, EPS estimates have seen 2 upward revisions and 0 downward. The EPS 1 month trend is $-0.42, the last 2 month trend is $-0.42, and the 3 month trend is $-0.33.

Based on analysts, the average revenue estimation is $39.89M, with a low revenue estimation of $38.52M, and a high estimation of $41.54M.

Clovis Oncology Previous Earnings Dates & Reports

CLVS Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Clovis Oncology's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.

CLVS Previous Earnings Date & Report Recap: Dec 2021 (FY)

Clovis Oncology's previous annual earnings date was Feb 23, 2022 for its fiscal year ended Dec 31, 2021.

CLVS's earnings per share (EPS) was $-2.29, beating the consensus analysts forecast of $-2.33 by -1.72% , and higher than the previous year's EPS (Dec 2020) by -48.54%.

Revenues were $148.76M, worse than the forecast of $150.25M by -0.99%, and down by -9.58% from previous year's revenue.

The company reported a net income of $-264.52M.

Clovis Oncology reported a free cash flow of $-196.37M for its fiscal year, compared to $-261.08M a year ago.

The company ended the fiscal year with $638.37M in total debt, a decrease of -1.32% compared to the previous year.